US Patent 7592352 Substituted thieno and furo-pyridines

Patent 7592352 was granted and assigned to Smithkline Beecham Limited on September, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Smithkline Beecham Limited

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7592352

Date of Patent

September 22, 2009

Patent Application Number

10555796

Date Filed

April 29, 2004

Patent Citations Received

‌

US Patent 11912668 GCN2 and perk kinase inhibitors and methods of use thereof

Patent Primary Examiner

‌

Janet L. Andres

Patent abstract

This invention relates to newly identified compounds for treating and preventing tumors and cancers, and methods for treating proliferative diseases associated with the imbalance or inappropriate activity of tyrosine kinases implicated in proliferative diseases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7592352 Substituted thieno and furo-pyridines

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API